Pennisetum Purpureum in Sarcopenia Patients

NCT05911516 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-12-19

No results posted yet for this study

Summary

The purpose of this study was to investigate the effects of Pennisetum purpureum health food supplementation on muscle mass and muscle strength.

Conditions

Interventions

DIETARY_SUPPLEMENT

Pennisetum purpureum

300mg Participants received 900mg of Pennisetum purpureum orally daily for 12 weeks

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • Taipei Medical University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05911516 on ClinicalTrials.gov